Raj Indupuri

Co-Founder and Chief Executive Officer eClinical Solutions

Last Reviewed: September 26, 2026

Executive Summary

Raj Indupuri is co-founder and Chief Executive Officer of eClinical Solutions, a Massachusetts company that builds software and services for managing the data generated by clinical trials. Founded in 2012 with Bob Arnesen, now its president, the company is centred on the elluminate Clinical Data Cloud, a SaaS platform for acquiring, processing and analysing trial data, and says it works with 16 of the top 50 biopharmaceutical companies. Indupuri, a mechanical engineer by training with an MBA from Boston University, has led the business through two rounds of private equity: a Summit Partners minority stake in 2020 and a majority investment by GI Partners in 2024, after which the founders kept significant equity.

Career Highlights

• Co-founder and CEO of eClinical Solutions, founded in 2012, responsible for the company’s overall direction and technology strategy.
• Signed the company’s January 2020 SEC Form D as Chief Executive Officer, which recorded $19.25 million in equity sold; Summit Partners has held a minority stake since 2020.
• Led the company into a majority growth investment by GI Partners, announced in September 2024, with Summit Partners and the founders remaining shareholders.
• Earlier worked at the biopharmaceutical company Serono on databases and software.
• Holds an MBA from Boston University.

Professional Journey

Indupuri grew up in India and trained as a mechanical engineer. His route into life sciences ran through data rather than the laboratory: at Serono, the biopharmaceutical company, he worked on databases and software, and has said that was where he came to appreciate the value of innovative therapeutics. The company describes him as having been part of the evolution of clinical data management for more than two decades. He also earned an MBA from Boston University.

In 2012 he co-founded eClinical Solutions with Bob Arnesen. Recalling the founding in 2024, Indupuri said the two had set out to create frictionless data flows, enabled by cloud and digital platforms, to make trials more efficient. The company developed the elluminate Clinical Data Cloud alongside biometrics and data services, and organised its work around acquiring research data, the infrastructure to process it, and the analytics that turn it into decisions. He has described the pandemic as accelerating the move to digital and decentralised trials, and the company as applying AI and machine learning to automate manual processes in trial data work.

Outside capital arrived in 2020. That January the company filed a Form D, signed by Indupuri as chief executive, recording a $19.25 million equity sale, and Summit Partners has held a minority stake since that year. In September 2024 eClinical Solutions announced a majority growth investment from GI Partners, on undisclosed terms, with Summit keeping its position and the founders retaining significant equity. Indupuri said the backing would help deepen the product roadmap, extend embedded AI capabilities and drive “future-ready trials”.

As CEO he sets the company’s vision and technology strategy, leading an executive team that includes Arnesen as president, a chief technology officer and a chief transformation and AI officer.

Education

Boston University

MBA

He also trained as a mechanical engineer; the institution for that degree was not stated in any source read.